Keywords: vertex, biochem, mdr, drug, enters, phase, ii

Vertex, BioChem's MDR Drug Enters Phase II

Article | 18 September 1997

Vertex Pharmaceuticals and BioChem Therapeutic have begun a PhaseII trial of Vertex' multidrug resistance inhibitor Incel (biricodar dicitrate, VX-710), plus ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Paclitaxel

Taxol

Nystatin

Go to drug listing